Myriam Martin Selected Research

Complement C4b-Binding Protein

11/2016	Complement in removal of the dead - balancing inflammation.
4/2012	Early complementopathy after multiple injuries in humans.
7/2009	Complement activation and plasma levels of C4b-binding protein in critical limb ischemia patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Myriam Martin Research Topics

Disease

4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2016 - 02/2010
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2012
3	Inflammation (Inflammations) 11/2016 - 07/2009
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2010 - 12/2009
1	Hemophilia B (Haemophilia B) 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2022
1	Atypical Hemolytic Uremic Syndrome 12/2021
1	Hemolysis 01/2021
1	Pulmonary Embolism 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Venous Insufficiency 01/2020
1	Venous Thromboembolism 01/2020
1	Lupus Nephritis 12/2017
1	Thrombotic Microangiopathies 01/2017
1	Hemorrhage 12/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2016
1	Thrombocytopenia (Thrombopenia) 12/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2016
1	Glomerulonephritis 08/2013
1	Multiple Trauma (Multiple Injuries) 04/2012
1	Wounds and Injuries (Trauma) 04/2012
1	Colitis 12/2009
1	Chronic Disease (Chronic Diseases) 12/2009
1	Chronic Limb-Threatening Ischemia 07/2009
1	Infections 06/2007

Drug/Important Bio-Agent (IBA)

7	Complement System Proteins (Complement)IBA 12/2021 - 12/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2013
3	Complement C4b-Binding ProteinIBA 11/2016 - 07/2009
2	AutoantibodiesIBA 01/2022 - 02/2010
2	AntibodiesIBA 01/2022 - 08/2013
2	Nadroparin (Nadroparin Calcium)IBA 01/2020 - 12/2016
2	AnticoagulantsIBA 01/2020 - 12/2016
2	Complement Inactivating AgentsIBA 01/2020 - 11/2016
2	Complement Factor H (Factor H)IBA 01/2020 - 11/2016
2	Annexin A2 (Annexin II)IBA 09/2012 - 02/2010
2	LigandsIBA 09/2012 - 02/2010
1	Neutralizing AntibodiesIBA 01/2022
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2022
1	Complement C4 (Complement Component 4)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	anti-dsDNA autoantibodyIBA 12/2017
1	Heparin (Liquaemin)FDA LinkGeneric 12/2016
1	AutoantigensIBA 11/2016
1	ChromatinIBA 08/2015
1	Histones (Histone)IBA 08/2013
1	Fibrinogen (Factor I)FDA Link 04/2012
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 04/2012
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 04/2012
1	Dextrans (Dextran)FDA Link 06/2010
1	SodiumIBA 06/2010
1	Anaphylatoxin C5a ReceptorIBA 12/2009
1	Dextran SulfateIBA 12/2009
1	Interleukin-4 (Interleukin 4)IBA 12/2009
1	Protein Isoforms (Isoforms)IBA 07/2009
1	Interferon-gamma (Interferon, gamma)IBA 06/2007

Therapy/Procedure

1	Immunotherapy 01/2020
1	Aftercare (After-Treatment) 01/2017
1	Therapeutics 12/2016